Study links continuous glucose monitoring to better glycemic control

11/27/2011 | PhysiciansBriefing.com

Intermittent real-time continuous glucose monitoring for three months improved and sustained glycemic control better than self-monitoring in patients with type 2 diabetes who were not on prandial insulin treatment, researchers reported in Diabetes Care. Researchers noted a greater decline in hemoglobin A1C levels, without the need for intensified medications, in those who had RT-CGM compared with those in the self-monitoring group.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA